Histone modifications in cervical cancer: Epigenetic mechanisms, functions and clinical implications (Review)
Oncology Reports · 01.08.2025 · 54 (4) · 1-14
DOI: 10.3892/or.2025.8964 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Oncology Reports, online erschienen am 01.08.2025. Verfasst von Xuewei Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, Jilin 130021, P.R. China. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Epigenesis, Genetic, Histones, Histone Code. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 160 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynecology, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, Jilin 130021, P.R. China.
- Department of Endocrinology, The Affiliated Hospital of Changchun University to Chinese Medicine, Changchun, Jilin 130021, P.R. China.
- Department of Traditional Chinese Medicine, 964th Hospital, Changchun, Jilin 130062, P.R. China.
Zitieren
APA
Li, X., Zhou, M., Yu, J., Yu, S., & Ruan, Z. (2025). Histone modifications in cervical cancer: Epigenetic mechanisms, functions and clinical implications (Review). Oncology Reports, 54(4), 1-14. https://doi.org/10.3892/or.2025.8964
Vancouver
Li X, Zhou M, Yu J, Yu S, Ruan Z. Histone modifications in cervical cancer: Epigenetic mechanisms, functions and clinical implications (Review). Oncology Reports. 2025;54(4):1-14. doi:10.3892/or.2025.8964
BibTeX
@article{Li2025,
author = {Li, Xuewei and Zhou, Min and Yu, Jing and Yu, Shaohui and Ruan, Zheng},
title = {Histone modifications in cervical cancer: Epigenetic mechanisms, functions and clinical implications (Review)},
journal = {Oncology Reports},
year = {2025},
volume = {54},
number = {4},
pages = {1--14},
doi = {10.3892/or.2025.8964}
}
EUVIMED